Hospital Pharmacy - April 2018 - 100

100

Hospital Pharmacy 53(2)

Table 2. Sample Financial Itemization of MS/PGY1/PGY2 HSPA
Residency.
Financial investment
Stipend + benefits (25%)a
Master's education and
feesb
Researchc
Travel
Preceptor timed
Accreditation feese
Total
Cost avoidance
Medicare pass-through
fundsf
Grants (variable)
Drug cost reduction
Projects
Preceptingg
Staffingh
CE experiences
Total
Return on investment

Year 0

Year 1

Year 2

$0
$0

$56 250
$27 804.94

$112 500
$55 609.88

$0
$1000
$0
$1000
$2000

$100
$1000
$50 000
$1000
$136 154.94

$200
$2000
$100 000
$1000
$271 309.88

$0

$54 461.98

$54 461.98

$0
$0

$20 000
$50 000

$40 000
$100 000

$30 000
$23 040
$500
$178 001.98
$41 847.04

$60 000
$46 080
$1000
$301 541.98
$30 232.10

$0
$0
$0
$0
−$2000

Note. HSPA = health-system pharmacy administration.
a
Year 1 will only have 1 PGY1 resident; Year 2 will have 1 PGY1 and 1
PGY2 resident.
b
Calculated based on out-of-state tuition/fees of $13 902.47 per semester.
Should be adjusted to $5296.97 per semester for in-state residents.
c
Research grants will be the individual resident's responsibility, $100 is
allocated for poster preparation.
d
$20 hours per week of preceptor time needed per resident.
e
$1000 initial application fee (Year 0), with a yearly increase of $1000 in
accreditation fees.
f
Medicare reimburses for pharmacy residency programs at the total
expense calculated above times the institution's Medicare load assumed
to be 40%.
g
Fifteen hours weekly of preceptor support.
h
Staffing includes 24 hours/month on weekends and 8 hours/month on
weekdays, totaling 32 hours/month.

leaders, as well as to progress pharmacy practice at the
respective educational sites. While HSPA programs have
been well established at academic medical centers, there is
demonstrable benefit of these programs at large community
health-systems. HSPA residents provide the opportunity to
build a pipeline of high-quality leaders, provide high-level
project involvement, and produce a positive ROI to benefit
the health-system and its patients.
Declaration of Conflicting Interests
The author(s) declared no potential conflicts of interest with respect
to the research, authorship, and/or publication of this article.

Funding
The author(s) received no financial support for the research, authorship, and/or publication of this article.

References
1. White SJ. Will there be a pharmacy leadership crisis? an ASHP
Foundation Scholar-in-Residence report. Am J Health Syst
Pharm. 2005;62:845-855.
2. Granko RP, Wolfe AS, Kelley LR, Morton CS, Delgado O.
Assessing the self-development potential of a pharmacy management practitioner through self-assessment survey. Am J
Health Syst Pharm. 2015;72(2):149-157.
3. Dunn L, Becker S. 50 things to know about the hospital
industry. Becker's Hospital Review. July 23, 2013. http://
www.beckershospitalreview.com/hospital-managementadministration/50-things-to-know-about-the-hospital-industry.
html. Accessed July 6, 2017.
4. Smith KM, Sorensen T, Connor K, et al. Value of conducting
pharmacy residency training-the organizational perspective
pharmacotherapy. Pharmacother. 2010;30(12):490e-510e.
5. UNC Eshelman School of Pharmacy. The MS. Date unknown.
https://pharmacy.unc.edu/academics/the-ms/. Accessed July 6,
2017.
6. American Society of Health-System Pharmacists. American
Society of Health-System Pharmacists (ASHP) resident match
statistics. National Matching Services Inc. Date unknown.
https://www.natmatch.com/ashprmp/stats.html. Accessed July
31, 2017.
7. American Society of Health-System Pharmacists. Online
ASHP residency directory. American Society of HealthSystem Pharmacists. Date unknown. https://accred.ashp.org/
aps/pages/directory/residencyprogramsearch.aspx. Accessed
July 31, 2017.
8. Miller DE, Woller TW. Understanding reimbursement for
pharmacy residents. Am J Health Syst Pharm. 1998;55:16201623.
9. Pasek P, Stephens C. Return on investment of a pharmacy residency training program. Am J Health Syst Pharm.
2010;67:1952-1957.
10. American Society of Health-System Pharmacists. Accreditation standard for postgraduate year one (PGY1) pharmacy
residency programs. American Society of Health-System
Pharmacists. Published 2016. https://www.ashp.org/professional-development/residency-information/residency-program-directors/residency-accreditation. Accessed July 31,
2017.
11. American Society of Health-System Pharmacists. Accreditation
standard for postgraduate year two (PGY2) pharmacy residency
programs. American Society of Health-System Pharmacists.
Date unknown. https://www.ashp.org/professional-development/residency-information/residency-program-directors/residency-accreditation. Accessed July 31, 2017.


http://www.beckershospitalreview.com/hospital-management-administration/50-things-to-know-about-the-hospital-industry.html http://www.beckershospitalreview.com/hospital-management-administration/50-things-to-know-about-the-hospital-industry.html http://www.beckershospitalreview.com/hospital-management-administration/50-things-to-know-about-the-hospital-industry.html http://www.beckershospitalreview.com/hospital-management-administration/50-things-to-know-about-the-hospital-industry.html https://pharmacy.unc.edu/academics/the-ms/ https://www.natmatch.com/ashprmp/stats.html https://accred.ashp.org/aps/pages/directory/residencyprogramsearch.aspx https://accred.ashp.org/aps/pages/directory/residencyprogramsearch.aspx https://www.ashp.org/professional-development/residency-information/residency-program-directors/residency-accreditation https://www.ashp.org/professional-development/residency-information/residency-program-directors/residency-accreditation https://www.ashp.org/professional-development/residency-information/residency-program-directors/residency-accreditation https://www.ashp.org/professional-development/residency-information/residency-program-directors/residency-accreditation https://www.ashp.org/professional-development/residency-information/residency-program-directors/residency-accreditation https://www.ashp.org/professional-development/residency-information/residency-program-directors/residency-accreditation

Table of Contents for the Digital Edition of Hospital Pharmacy - April 2018

Ed Board
TOC
HPX
Why Is Burnout a Taboo?
Stability of 2 mg/mL Adenosine Solution in Polyvinyl Chloride and Polyolefin Infusion Bags
Glecaprevir/Pibrentasvir
New Medications in the Treatement of Acute Decompensated Heart Failure
The Prescription Drug User Fee Act: Cause for Concern?
ISMP Medication Error Report Analysis
ISMP Adverse Drug Reactions
Development and Implementation of a Combined Master of Science and PGY1/PGY2 Health-System Pharmacy Administration Residency Program at a Large Community Teaching Hospital
Breadth of Statistical Training Among Pharmacy Residency Programs Across the United States
Antihypertensive Prescription Pattern and Compliance to JNC 7 and JNC 8 at Tertiary Care Government Hospital, Hyderabad, India: A Cross-sectional Retrospective Study
Changes in Pharmacy Residency Training Design Between 2012 and 2017: A Perspective of Academic Medical Centers
Incidence of Hypoglycemia in Burn Patients: A Focus for Process Improvement
Physical Compatibility of Micafungin With Sodium Bicarbonate Hydration Fluids Commonly Used With High-Dose Methotrexate Chemotherapy
Hospital Pharmacy - April 2018 - Cover1
Hospital Pharmacy - April 2018 - Cover2
Hospital Pharmacy - April 2018 - Ed Board
Hospital Pharmacy - April 2018 - TOC
Hospital Pharmacy - April 2018 - HPX
Hospital Pharmacy - April 2018 - Why Is Burnout a Taboo?
Hospital Pharmacy - April 2018 - Stability of 2 mg/mL Adenosine Solution in Polyvinyl Chloride and Polyolefin Infusion Bags
Hospital Pharmacy - April 2018 - 74
Hospital Pharmacy - April 2018 - Glecaprevir/Pibrentasvir
Hospital Pharmacy - April 2018 - 76
Hospital Pharmacy - April 2018 - 77
Hospital Pharmacy - April 2018 - 78
Hospital Pharmacy - April 2018 - 79
Hospital Pharmacy - April 2018 - 80
Hospital Pharmacy - April 2018 - 81
Hospital Pharmacy - April 2018 - 82
Hospital Pharmacy - April 2018 - 83
Hospital Pharmacy - April 2018 - 84
Hospital Pharmacy - April 2018 - New Medications in the Treatement of Acute Decompensated Heart Failure
Hospital Pharmacy - April 2018 - 86
Hospital Pharmacy - April 2018 - 87
Hospital Pharmacy - April 2018 - The Prescription Drug User Fee Act: Cause for Concern?
Hospital Pharmacy - April 2018 - 89
Hospital Pharmacy - April 2018 - ISMP Medication Error Report Analysis
Hospital Pharmacy - April 2018 - 91
Hospital Pharmacy - April 2018 - 92
Hospital Pharmacy - April 2018 - ISMP Adverse Drug Reactions
Hospital Pharmacy - April 2018 - 94
Hospital Pharmacy - April 2018 - 95
Hospital Pharmacy - April 2018 - Development and Implementation of a Combined Master of Science and PGY1/PGY2 Health-System Pharmacy Administration Residency Program at a Large Community Teaching Hospital
Hospital Pharmacy - April 2018 - 97
Hospital Pharmacy - April 2018 - 98
Hospital Pharmacy - April 2018 - 99
Hospital Pharmacy - April 2018 - 100
Hospital Pharmacy - April 2018 - Breadth of Statistical Training Among Pharmacy Residency Programs Across the United States
Hospital Pharmacy - April 2018 - 102
Hospital Pharmacy - April 2018 - 103
Hospital Pharmacy - April 2018 - 104
Hospital Pharmacy - April 2018 - 105
Hospital Pharmacy - April 2018 - 106
Hospital Pharmacy - April 2018 - Antihypertensive Prescription Pattern and Compliance to JNC 7 and JNC 8 at Tertiary Care Government Hospital, Hyderabad, India: A Cross-sectional Retrospective Study
Hospital Pharmacy - April 2018 - 108
Hospital Pharmacy - April 2018 - 109
Hospital Pharmacy - April 2018 - 110
Hospital Pharmacy - April 2018 - 111
Hospital Pharmacy - April 2018 - 112
Hospital Pharmacy - April 2018 - Changes in Pharmacy Residency Training Design Between 2012 and 2017: A Perspective of Academic Medical Centers
Hospital Pharmacy - April 2018 - 114
Hospital Pharmacy - April 2018 - 115
Hospital Pharmacy - April 2018 - 116
Hospital Pharmacy - April 2018 - 117
Hospital Pharmacy - April 2018 - 118
Hospital Pharmacy - April 2018 - 119
Hospital Pharmacy - April 2018 - 120
Hospital Pharmacy - April 2018 - Incidence of Hypoglycemia in Burn Patients: A Focus for Process Improvement
Hospital Pharmacy - April 2018 - 122
Hospital Pharmacy - April 2018 - 123
Hospital Pharmacy - April 2018 - 124
Hospital Pharmacy - April 2018 - Physical Compatibility of Micafungin With Sodium Bicarbonate Hydration Fluids Commonly Used With High-Dose Methotrexate Chemotherapy
Hospital Pharmacy - April 2018 - 126
Hospital Pharmacy - April 2018 - 127
Hospital Pharmacy - April 2018 - 128
Hospital Pharmacy - April 2018 - Cover3
Hospital Pharmacy - April 2018 - Cover4
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_december2020
https://www.nxtbook.com/nxtbooks/sage/psychologicalscience_demo
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_october2020
https://www.nxtbook.com/nxtbooks/sage/fai_202009
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_august2020
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_june2020
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_april2020
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_february2020
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_december2019
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_october2019
https://www.nxtbook.com/nxtbooks/sage/fai_201909
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_july2019
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_june2019
https://www.nxtbook.com/nxtbooks/sage/canadianpharmacistsjournal_05062019
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_april2019
https://www.nxtbook.com/nxtbooks/sage/sri_supplement_201903
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_february2019
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_december2018
https://www.nxtbook.com/nxtbooks/sage/tec_20180810
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_october2018
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_julyaugust2018
https://www.nxtbook.com/nxtbooks/sage/fai_201807
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_june2018
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_april2018
https://www.nxtbook.com/nxtbooks/sage/sri_supplement_201803
https://www.nxtbook.com/nxtbooks/sage/slas_discovery_201712
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_february2018
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_december2017
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_november2017
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_october2017
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_september2017
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_julyaugust2017
https://www.nxtbook.com/nxtbooks/sage/fai_supplement_201709
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_june2017
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_may2017
https://www.nxtbook.com/nxtbooks/sage/fai_201706
https://www.nxtbook.com/nxtbooks/sage/fai_201607
https://www.nxtbookmedia.com